Company intelligence / Profile preview

Spinnaker International

Plymouth Meeting, Pennsylvania, United States

Ownership: Private
Development stage: Other

Overview

Spinnaker is a specialized clinical trial service provider focused on patient recruitment and retention for the global life sciences industry. The company provides strategic consulting and tactical execution to help pharmaceutical and biotechnology sponsors accelerate trial timelines by identifying and engaging eligible patient populations. Spinnaker utilizes data-driven methodologies and site-focused support to optimize the enrollment process across various therapeutic areas. In 2017, the company was acquired by WCG (WIRB-Copernicus Group) to enhance its suite of clinical trial optimization services.

Industry: Contract Research Organization

Partnerships

WCGVarious pharmaceutical and biotech sponsors

Beyond the preview

Go deeper on Spinnaker International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spinnaker International.

Explore the full profile